Becker's Healthcare October 22, 2024
A 12-year-old boy has become the first patient in the U.S. to receive gene therapy for sickle cell disease, The New York Times reported Oct. 21.
Kendric Cromer began treatment with Bluebird bio’s sickle cell gene therapy in May. Physicians removed stem cells from his bone marrow and sent them to a facility where new, healthy hemoglobin genes were added. It took a few months before the treated cells were ready for administration.
On Sept. 3, Kendric was admitted to Washington, D.C.-based Children’s National Hospital for the final phase of treatment. He underwent intensive chemotherapy to...
Today's Sponsors
Today's Sponsor